All One Health Content – Page 54
-
NewsAmericans say benefits of MMR vaccine for children outweigh risks by nearly 5-1
While many Americans know how measles can spread, most cannot accurately estimate the prevalence of complications associated with measles such as hospitalization or the risks it presents during pregnancy, according to a new survey.
-
NewsAI predicts bacterial resistance to cleaning agents
With the help of artificial intelligence and DNA decoding, a new method can predict how well disease-causing bacteria such as Listeria tolerate disinfectants. This research may become a valuable weapon in the fight against harmful bacteria.
-
NewsResearchers find CRISPR is capable of even more than we thought
Researchers studying key immune components of some CRISPR systems have announced the newest CARF effector they’ve discovered, which they coined Cat1 - it can deplete a metabolite essential for cellular function.
-
NewsNew treatment targets link between viral infection and Alzheimer’s disease
A unique mechanism triggering Alzheimer’s disease draws attention: viral infection—while ALT001 is confirmed to alleviate neuroinflammation and suppress viral replication.
-
NewsParticles carrying multiple vaccine doses could reduce the need for follow-up shots
Researchers are working to develop microparticles that can release their payload weeks or months after being injected. This could lead to vaccines that can be given just once, with several doses that would be released at different time points.
-
NewsThe Global Fund to fight AIDS, Tuberculosis and Malaria ‘should step up efforts’
The international community must protect global responses to HIV, tuberculosis (TB), and malaria to serve humanity’s collective interests, according to a new opinion article.
-
NewsTwo HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies
A new study combining data from two separate phase 1 clinical trials shows that a targeted vaccine strategy can successfully activate early immune responses relevant to HIV, and, in one trial, further advance them.
-
NewsScientists find two brain biomarkers in long COVID sufferers may be what’s causing brain fog
A new study that compares inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows those with cognitive issues have a lower ability to adapt to stress and higher levels of inflammation in their brains.
-
NewsWorld’s largest bat organoid platform paves the way for pandemic preparedness
Researchers have created the world’s most comprehensive bat organoid platform. These ’mini-organs’ are grown from five common bat species found across Asia and Europe and represent four different organs—airway, lungs, kidneys, and small intestine.
-
NewsCombining laboratory techniques yields wealth of information about deadly brain tumors
In a new study, researchers injected into the tumor a virus aimed at killing glioblastoma cells. Surgeons took tumor tissue samples and ran them through multiple advanced laboratory techniques to demonstrate that even small tissue samples can yield additional insights.
-
NewsYellow fever vaccination: how strong immune responses are triggered
Researchers have shown how specific immune cells are activated by the vaccine – an important starting point for the development of new vaccines.
-
NewsScientist awarded $500,000 Gruber Genetics Prize for pioneering discoveries in bacterial immune systems
The 2025 Gruber Genetics Prize is being awarded to geneticist and molecular biologist Rotem Sorek, Ph.D., of the Weizmann Institute of Science, for his discoveries in the immune system of bacteria.
-
NewsNew hope against superbugs: Promising antibiotic candidate discovered
An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial strains.
-
NewsScientists evaluate in-vitro activity of ceftazidime-avibactam against carbapenem-resistant gram-negative bacteria
Scientists explored the in-vitro activity of ceftazidime-avibactam (CAZ-AVI) in clinical isolates of carbapenem-resistant gram-negative bacteria collected at the outpatient, emergency, and inpatient departments of the Indus Hospital, Karachi.
-
NewsResearchers reveal lipid-based communication between body and gut microbes
A new study shows how a host protein can specifically recognize bacterial lipids, thus triggering beneficial immune responses. It also highlights a new way the body actively shapes the gut microbiome by communicating with microbes to maintain balance.
-
News New study reveals our skin’s own bacteria can help protect us from the bad effects of sunlight
Researchers have substantiated that certain skin bacteria can protect us from the sun’s ultraviolet (UV) radiation specifically by metabolizing cis-urocanic acid using an enzyme called urocanase. This enables the skin’s ability to fine-tune how it responds to UV radiation.
-
News‘Loop’hole: HIV-1 hijacks human immune cells using circular RNAs
In a groundbreaking discovery, researchers have identified a never-before-seen mechanism that enables the human immunodeficiency type 1 virus (HIV-1) to evade the body’s natural defenses and use it to support its survival and replication.
-
NewsFirst all-oral treatment for a rare but deadly strain of sleeping sickness now available
A handful of patients in Ethiopia, Malawi, Tanzania, Zambia, and Zimbabwe, as well as foreign travellers, have now been treated with a medicine that is revolutionizing care for patients with rhodesiense sleeping sickness.
-
NewsTo restore gut health, a healthy diet outperforms fecal transplants
When our microbial ranks are damaged or depleted — whether by inflammatory bowel diseases, antibiotic regimens or bone marrow transplants — it is crucial to restore them. According to a new study, the most effective way of rebuilding the microbiome is also the simplest: maintaining a healthy diet.
-
NewsScientists reveal key bacterial immune mechanism
Researchers have uncovered a pivotal mechanism by which bacteria defend themselves against viral infection. Cyclic dinucleotides (CDNs), synthesized during activation of the cyclic oligonucleotide-based anti-phage signaling system (CBASS) immune mechanism, trigger the filamentous assembly of phospholipase effectors, which execute the downstream immune response.